Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis.

AUTOR(ES)

Braunstein, G D

RESUMO

The serum concentrations of the myotrophic hormone insulin-like growth factor-I (IGF-I) in 23 patients with amyotrophic lateral sclerosis were not significantly different from those found in the sera of 13 control patients. There was no difference in binding of 125I-IGF-I by serum from patients with amyotrophic lateral sclerosis in comparison with that found in the controls. These results indicate that immunoreactive IGF-I concentrations are normal in patients with amyotrophic lateral sclerosis and that such patients do not have significant antibodies binding their endogenous IGF-I.

Documentos Relacionados

• Bioactive Insulin-Like Growth Factor-I in Obesity
• The Role of Liver-Derived Insulin-Like Growth Factor-I
• Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
• Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown*
• Susceptibility to Apoptosis in Insulin-like Growth Factor-I Receptor-deficient Brown Adipocytes